Center for Brain Research, Medical University of Vienna, Vienna, Austria; Institute of Neuropathology, University Medical Center, Göttingen, Germany.
Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Neuroimage. 2018 Oct 1;179:117-133. doi: 10.1016/j.neuroimage.2018.06.007. Epub 2018 Jun 15.
Quantitative susceptibility mapping (QSM) and effective transverse relaxation rate (R2*) mapping are both highly sensitive to variations in brain iron content. Clinical Magnetic Resonance Imaging (MRI) studies report changes of susceptibilities and relaxation rates in various neurological diseases which are often equated with changes in regional brain iron content. However, these mentioned metrics lack specificity for iron, since they are also influenced by the presence of myelin. In this study, we assessed the extent to which QSM and R2* reflect iron concentration as well as histological iron and myelin intensities. Six unfixed human post-mortem brains were imaged in situ with a 7 T MRI scanner. After formalin fixation, the brains were sliced axially and punched. 671 tissue punches were subjected to ferrozine iron quantification. Subsequently, brain slices were embedded in paraffin, and histological double-hemispheric axial brain slices were stained for Luxol fast blue (myelin) and diaminobenzidine (DAB)-enhanced Turnbull blue (iron). 3331 regions of interest (ROIs) were drawn on the histological stainings to assess myelin and iron intensities, which were compared with MRI data in corresponding ROIs. QSM more closely reflected quantitative ferrozine iron values (r = 0.755 vs. 0.738), whereas R2* correlated better with iron staining intensities (r = 0.619 vs. 0.445). Myelin intensities correlated negatively with QSM (r = -0.352), indicating a diamagnetic effect of myelin on susceptibility. Myelin intensities were higher in the thalamus than in the basal ganglia. A significant relationship was nonetheless observed between quantitative iron values and QSM, confirming the applicability of the latter in this brain region for iron quantification.
定量磁化率映射 (QSM) 和有效横向弛豫率 (R2*) 映射均对脑铁含量的变化非常敏感。临床磁共振成像 (MRI) 研究报告了各种神经疾病中磁化率和弛豫率的变化,这些变化通常与局部脑铁含量的变化相关。然而,这些提到的指标对铁缺乏特异性,因为它们也受到髓鞘的影响。在这项研究中,我们评估了 QSM 和 R2* 反映铁浓度以及组织铁和髓鞘强度的程度。使用 7T MRI 扫描仪对 6 个未经固定的人脑进行了原位成像。福尔马林固定后,将大脑轴向切片并打孔。671 个组织打孔样本进行了菲咯嗪铁定量。随后,脑切片被嵌入石蜡中,并对组织切片进行了卢索快速蓝(髓鞘)和二氨基联苯胺(DAB)增强的特恩布尔蓝(铁)双重染色。对组织学染色的 3331 个感兴趣区域(ROI)进行了绘制,以评估髓鞘和铁的强度,并将其与相应 ROI 中的 MRI 数据进行比较。QSM 更紧密地反映了定量菲咯嗪铁值(r=0.755 与 0.738),而 R2* 与铁染色强度的相关性更好(r=0.619 与 0.445)。髓鞘强度与 QSM 呈负相关(r=-0.352),表明髓鞘对磁化率有抗磁性影响。在丘脑,髓鞘强度比基底节高。然而,在定量铁值和 QSM 之间仍观察到显著的关系,证实了后者在该脑区铁定量中的适用性。